MacroGenics to Showcase at H.C. Wainwright's 27th Annual Global Investment Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 02 2025
0mins
Source: Globenewswire
Company Presentation Announcement: MacroGenics, Inc. will have its President & CEO, Eric Risser, present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 11:30am ET in New York, with a webcast available on their website.
Company Overview: MacroGenics is a biopharmaceutical company specializing in innovative antibody-based therapeutics for cancer treatment, leveraging proprietary technology platforms and strategic collaborations to develop its product pipeline.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
